Recognized for Expanding Women's Employment and Fair Personnel Management Systems

On September 11, Samsung Bioepis announced that it had been selected as a "2026 Korea's Best Employment Company" by the Ministry of Employment and Labor.

Samsung Bioepis is taking a commemorative photo after being selected as a "Best Job Creator in Korea 2026" by the Ministry of Employment and Labor. Samsung Bioepis

Samsung Bioepis is taking a commemorative photo after being selected as a "Best Job Creator in Korea 2026" by the Ministry of Employment and Labor. Samsung Bioepis

View original image

Korea's Best Employment Company is a government award established in 2010 by the Ministry of Employment and Labor to recognize private companies that have demonstrated exemplary performance in creating and improving high-quality jobs. Selected companies are eligible to receive various forms of support, including preferential treatment in credit evaluation and loan interest rates.


In this certification, Samsung Bioepis was highly praised for its efforts to expand employment opportunities for women and run fair personnel management systems. As of the end of last year, the company achieved a female employees ratio of 51% and a female manager ratio of 47%, contributing to the recruitment and development of outstanding female talent.


In addition, Samsung Bioepis is actively promoting work-life balance by strengthening maternity protection policies and implementing flexible work arrangements, while also striving for transparent communication between labor and management through CEO-led business update sessions.



Samsung Bioepis is continuing its efforts to build a healthy corporate culture, including being selected last year as an "Excellent Company for Gender Equality in Employment" and a "Best Practice Company in Labor-Management Culture," both hosted by the Ministry of Employment and Labor.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing